Circulating anti-immunoglobulin antibodies in recent-onset type I diabetic patients

Circulating anti-immunoglobulin antibodies in recent-onset type I diabetic patients. U Di Mario , F Dotta , L Crisa , E Anastasi , D Andreani , S A Dib and G S Eisenbarth Department of Endocrinology, University of Rome, La Sapienza, Italy. Abstract Human sera from 51 recent-onset insulin-dependent (...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 37; no. 4; pp. 462 - 466
Main Authors Di Mario, U., Dotta, F., Crisa, L., Anastasi, E., Andreani, D., Dib, S. A., Eisenbarth, G. S.
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.04.1988
Online AccessGet full text

Cover

Loading…
More Information
Summary:Circulating anti-immunoglobulin antibodies in recent-onset type I diabetic patients. U Di Mario , F Dotta , L Crisa , E Anastasi , D Andreani , S A Dib and G S Eisenbarth Department of Endocrinology, University of Rome, La Sapienza, Italy. Abstract Human sera from 51 recent-onset insulin-dependent (type I) diabetic patients and 47 unrelated control subjects were screened for the possible presence of circulating factors reacting with several anti-pancreatic islet monoclonal antibodies (MoAb.ISL) in solid-phase radioimmunoassay methods (the original goal being the detection of anti-idiotypic islet cell antibodies and/or specific islet cell antigen-bearing immune complexes). MoAbs from the parental myeloma cell line and purified immunoglobulins (Igs) from different animal species were controls. Type I diabetic sera showed significantly increased binding to MoAb.ISL-coated wells compared with normal subjects (P less than .001). However, the same sera also tended to show a higher binding to the control (non-islet-related) MoAb. Sera from type I diabetic patients also reacted with horse, bovine, pig, rabbit, and goat IgG. Displacement of the binding has been obtained by F(ab')2 and/or Fc fragments of IgG. Evidence has been obtained regarding a similar reaction with human IgM. All the sera were negative when tested for rheumatoid factor by nephelometry. The circulating antibodies described have been proven to be different from islet cell autoantibodies. An anti-Ig antibody is thus present in the sera of recent-onset diabetic patients and represents an additional immunological phenomenon with possible physiopathological and clinical significance.
ISSN:0012-1797
1939-327X
0012-1797
DOI:10.2337/diabetes.37.4.462